Administration of ranibizumab 0.5 mg through a treat-and-extend (T&E) regimen is statistically noninferior and clinically comparable with a monthly regimen in improving visual acuity (VA) in patients with neovascular age-related macular degeneration (nAMD), according to a recent study. Also, ranibizumab treatment confers no new safety signals.
There appears to be a significant U-shaped association between extreme systolic ocular perfusion pressure values and primary open-angle glaucoma (POAG) driven, in part, by decreased systolic blood pressure and intraocular pressure, a recent Singapore study has found.
Individuals who have a higher perception of barriers to diabetes self-management may be at an elevated risk for diabetic retinopathy (DR), according to findings of the Singapore Diabetes Management Project study.
Fingerprick autologous blood (FAB) appears to be effective and safe in the treatment of severe dry eye syndrome (DES), eliminating the need for blood donation and specialist processing, as reported in a pilot study.
Individuals with diabetic retinopathy (DR) appear to have thicker macula and outer retina compared with those who do not have the diabetic eye disease, and such thickening is more pronounced in eyes with severe DR, according to a study.
New drug applications approved by US FDA as of 16 - 31 December 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Individuals with mild-to-moderate non-proliferative diabetic retinopathy appear to have an elevated risk of falls compared with individuals with diabetes but no diabetic retinopathy, according to a Singapore study.
Refractive errors are ocular disorders that occur when the optical power of the eye produces an object image that is not focused on the retina. Although easily correctable in developed countries, the global burden of uncorrected refractive errors is enormous, with an estimated 145 million visually impaired and 8 million blind individuals.
Audrey Abella spoke with Dr Inez Wong, senior consultant ophthalmologist and director of paediatric ophthalmology and strabismus service at the Eagle Eye Centre in Singapore, on how GPs can manage refractive errors in the primary care setting.
New drug applications approved by US FDA as of 1 - 15 November 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
An organic light-emitting diode sleep mask appears to have potential therapeutic value in diabetic macular oedema (DMO), producing a beneficial effect on retinal thickness with no major safety signal apart from a small impairment in daytime alertness and a moderate impact on wellbeing, a study has shown.